The Journal of Pediatrics
Volume 149, Issue 6 , Pages 746-754 , December 2006

Pharmacologic treatment of hypertension in children and adolescents

  • Joseph T. Flynn, MD, MS

      Affiliations

    • Division of Pediatric Nephrology, Children’s Hospital at Montefiore and Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York
    • Dr Flynn is a paid consultant to AstraZeneca, Novartis, PDL BioPharma, and Pfizer.
    • Corresponding Author InformationReprint requests: Joseph T. Flynn, MD, MS, Division of Pediatric Nephrology, Montefiore Medical Center, 111 East 210th St, Bronx, NY 10467.
    • ,
  • Stephen R. Daniels, MD, PhD

      Affiliations

    • Department of Pediatrics, University of Colorado School of Medicine and The Children’s Hospital of Denver, Denver, Colorado

Received 26 April 2006 ,Revised 7 July 2006 ,Accepted 30 August 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0022-3476(06)00837-7

doi: 10.1016/j.jpeds.2006.08.074

The Journal of Pediatrics
Volume 149, Issue 6 , Pages 746-754 , December 2006

Article Tools

* Image Usage & Resolution